---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-005454"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2026-01-21T23:59:59+00:00"
generated_at: "2026-05-16T09:16:01.432824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ocugen prices $22.5M common stock offering at $1.50/share; led by RTW Investments

## Summary
- Priced 15M shares of common stock at $1.50/share for gross proceeds of $22.5M; net proceeds ~$20.8M.
- Offering led by RTW Investments with participation from new and existing investors; expected to close Jan 22, 2026.
- Proceeds to be used for general corporate purposes, capital expenditures, working capital, and G&A.
- Oppenheimer & Co. acting as sole book-running manager for the offering.

## SEC filing metadata
- accession: 0001104659-26-005454
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2026-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/0001104659-26-005454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/tm263710d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-005454
- JSON: https://secwatch.observer/filing/0001104659-26-005454.json
- Plain text: https://secwatch.observer/filing/0001104659-26-005454.txt

## Key facts
- Material Agreements
  Ocugen, Inc. entered into Underwriting Agreement with Oppenheimer & Co. Inc. valued at 15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million (effective 2026-01-20).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Oppenheimer & Co. Inc.
  - Value: 15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million
  - Effective: 2026-01-20
  source text: On January 20, 2026, Ocugen, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. (the “ Underwriter ”), pursuant to which the Company agreed to issue and sell to the Underwriter, in an offering (the “ Offering ”) 15,000,000 shares of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”), at an offering price of $1.50 per share (the “ Offering Price ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372299/000110465926005454/0001104659-26-005454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.